As a member of the nuclear receptor superfamily, ER exists in two primary isoforms: ERα (encoded by ESR1) and ERβ (encoded by ESR2), with ERα being the predominant and clinically relevant isoform in most hormone-positive breast cancers. Here, ESR2 is linked to breast carcinoma.